TABLE 7.

Performance of the COBAS AMPLICOR HCV Test v2.0 compared to serological, biochemical, and histological findings in the diagnosis patient group

Histological findings	Serology results	No. of PCR- positive cases	No. of PCR- negative cases	% Proportion agreeing with EIA results (95% CI)a
Elevated ALT and hepatitis	EIA+/RIBA+	162	2	98.8 (95.7–99.8)
	EIA+/RIBA IND	2	0	100.0 (15.8–100.0)
	EIA+/RIBA−	0	0
	EIA−	0	16	100.0 (79.4–100.0)
Normal ALT and hepatitis	EIA+/RIBA+	58	0	100.0 (93.8–100.0)
	EIA+/RIBA IND	1	0	100.0 (2.5–100.0)
	EIA+/RIBA−	0	0
	EIA−	0	9	100.0 (66.4–100.0)
Elevated ALT and no hepatitis	EIA+/RIBA+	1	0	100.0 (2.5–100.0)
	EIA+/RIBA IND	0	0
	EIA+/RIBA−	0	0
	EIA−	0	19	100.0 (82.4–100.0)
Normal ALT and no hepatitis	EIA+/RIBA+	0	1	0.0 (0.0–97.5)
	EIA+/RIBA IND	1	0	100.0 (2.5–100.0)
	EIA+/RIBA−	0	0
	EIA−	1	21	95.5 (77.2–99.9)

^aCI, confidence interval.